Vialwirebiotech, curated
November 21, 2026, 4:48 PM
August 1, 2026
- 10:00 AM · SCMP — Tech10:00 AMPain or gain? US moves to decouple its defence industry from China’s rare earths — SCMP — Tech
July 31, 2026
- 4:47 PM · Bloomberg — Technology4:47 PMIllumina CEO on Genomic Sequencing Opportunities and AI — Bloomberg — Technology
- 12:00 PM · BioWorld12:00 PMWith sleep apnea drug under review, Apnimed prices $192M IPO — BioWorld
- 12:00 PM · BioWorld12:00 PMMimedx to buy Sanara for $350M to move beyond wound care — BioWorld
- 12:00 PM · BioWorld12:00 PMLow coffers, failed endometrial cancer trial: Karyopharm down 72% — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMResilience and Lilly invest $750M to boost Cincinnati drug production — BioPharma Dive
- 10:42 AM · Drug Discovery World10:42 AMTreatment underway for nonobstructive hypertrophic cardiomyopathy — Drug Discovery World
- 9:19 AM · Drug Discovery World9:19 AMGSK teams up with Relation to improve disease biology knowledge — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMSunrock Biopharma reports new CCR9-targeting ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMSitala Bio identifies new complement factor B inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMMira advances MIRA-55 and SKNY-1 — BioWorld
- 9:00 AM · BioWorld9:00 AMCreate Medicines’ CRT-402 cleared to enter clinic in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMTSC Alliance and Apertura Gene Therapy collaboration progresses — BioWorld
- 9:00 AM · BioWorld9:00 AMTuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMApex Bioscience discovers new PDE4 and PDE5 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMLiver-targeted ASO tackles early MASLD — BioWorld
- 9:00 AM · BioWorld9:00 AMOlix’s OLX-501A reduces visceral fat in obese NHPs — BioWorld
- 9:00 AM · BioWorld9:00 AMUMF-814A sheds light on spliceosome-mutant myeloid disorders — BioWorld
- 9:00 AM · BioWorld9:00 AMTaisho licenses Japanese rights to Kaigene’s KG-006 — BioWorld
- 9:00 AM · BioWorld9:00 AMTahrget Therapeutics discloses new viral DNA polymerase inhibitors — BioWorld
- 8:32 AM · STAT News
- 6:57 AM · Pharmaceutical Technology6:57 AMSublingual semaglutide offered to UK practices despite Novo Nordisk concerns — Pharmaceutical Technology
- 5:58 AM · Pharmaceutical Technology5:58 AMmiRecule and Rio Biofarma to develop RNA therapeutic delivery technologies — Pharmaceutical Technology
- 4:47 AM · Drug Discovery World4:47 AMVerdiva Bio initiates Phase I study of obesity drug — Drug Discovery World
- 4:00 AM · Labiotech (EU)4:00 AMGain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson’s — Labiotech (EU)